Literature DB >> 7686184

Identification of four epitopes in hepatitis C virus core protein.

P Ferroni1, G Mascolo, M Zaninetti, D Colzani, F Pregliasco, M Pirisi, F Barbone, V Gasparini.   

Abstract

We identified four epitopes in hepatitis C virus core protein by using the algorithm of Jameson and Wolf. G15V (amino acids [aa] 31 to 45) appears to be the immunodominant epitope, since it was able to detect antibodies to the core protein in all 40 patients and in 44 of 45 recombinant immunoblot assay-confirmed positive blood donors. This epitope is associated with a low frequency of false-positive results, as found with 522 negative blood donors. A strong reactivity was also observed with the Q15V epitope (aa 7 to 21), although this was associated with low specificity. Occasional reactivity to the R15P (aa 49 to 63) and P15R (aa 99 to 113) epitopes was observed. Q15V and G15V detected antibodies to core protein earlier than the other two epitopes.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7686184      PMCID: PMC265582          DOI: 10.1128/jcm.31.6.1586-1591.1993

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  29 in total

1.  Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome.

Authors:  Q L Choo; G Kuo; A J Weiner; L R Overby; D W Bradley; M Houghton
Journal:  Science       Date:  1989-04-21       Impact factor: 47.728

2.  Two-stage transformation systems for normalization of reference distributions evaluated.

Authors:  K Linnet
Journal:  Clin Chem       Date:  1987-03       Impact factor: 8.327

3.  An integrated family of amino acid sequence analysis programs.

Authors:  H Wolf; S Modrow; M Motz; B A Jameson; G Hermann; B Förtsch
Journal:  Comput Appl Biosci       Date:  1988-03

4.  Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides.

Authors:  E Kaiser; R L Colescott; C D Bossinger; P I Cook
Journal:  Anal Biochem       Date:  1970-04       Impact factor: 3.365

5.  Prediction of protein antigenic determinants from amino acid sequences.

Authors:  T P Hopp; K R Woods
Journal:  Proc Natl Acad Sci U S A       Date:  1981-06       Impact factor: 11.205

6.  Analysis of the accuracy and implications of simple methods for predicting the secondary structure of globular proteins.

Authors:  J Garnier; D J Osguthorpe; B Robson
Journal:  J Mol Biol       Date:  1978-03-25       Impact factor: 5.469

7.  Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis.

Authors:  H J Alter; R H Purcell; J W Shih; J C Melpolder; M Houghton; Q L Choo; G Kuo
Journal:  N Engl J Med       Date:  1989-11-30       Impact factor: 91.245

8.  An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis.

Authors:  G Kuo; Q L Choo; H J Alter; G L Gitnick; A G Redeker; R H Purcell; T Miyamura; J L Dienstag; M J Alter; C E Stevens
Journal:  Science       Date:  1989-04-21       Impact factor: 47.728

9.  Experimental infection of chimpanzees with antihemophilic (factor VIII) materials: recovery of virus-like particles associated with non-A, non-B hepatitis.

Authors:  D W Bradley; E H Cook; J E Maynard; K A McCaustland; J W Ebert; G H Dolana; R A Petzel; R J Kantor; A Heilbrunn; H A Fields; B L Murphy
Journal:  J Med Virol       Date:  1979       Impact factor: 2.327

10.  Induction of hepatitis A virus-neutralizing antibody by a virus-specific synthetic peptide.

Authors:  E A Emini; J V Hughes; D S Perlow; J Boger
Journal:  J Virol       Date:  1985-09       Impact factor: 5.103

View more
  9 in total

1.  Hepatitis C viraemia and antibody to core epitopes in anti-HCV ELISA negative blood donors.

Authors:  P Ferroni; V Gasparini; M Zaninetti; D Colzani; G Mascolo
Journal:  Eur J Epidemiol       Date:  1994-10       Impact factor: 8.082

2.  Immunoreactivity to putative B-cell epitopes of hepatitis G virus polyprotein in viremic and nonviremic subjects.

Authors:  P Toniutto; C Fabris; F Barbone; S G Tisminetzky; D Liani; T Galai; G Barillari; F Biffoni; V Gasparini; M Pirisi
Journal:  Clin Diagn Lab Immunol       Date:  1999-07

3.  Improved reactivity of hepatitis C virus core protein epitopes in a conformational antigen-presenting system.

Authors:  E Buratti; M Di Michele; P Song; C Monti-Bragadin; E A Scodeller; F E Baralle; S G Tisminetzky
Journal:  Clin Diagn Lab Immunol       Date:  1997-03

4.  Expression and immunoreactivity of an epitope of HCV in a foreign epitope presenting system.

Authors:  Mei Peng; Chang-Bai Dai; Yuan-Ding Chen
Journal:  World J Gastroenterol       Date:  2005-06-14       Impact factor: 5.742

5.  Analysis of the core and E1 envelope region sequences of a novel variant of hepatitis C virus obtained in Indonesia.

Authors:  H Hotta; H Doi; T Hayashi; M Purwanta; W Soemarto; M Mizokami; K Ohba; M Homma
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

6.  Isotype-specific immune response to a single hepatitis C virus core epitope defined by a human monoclonal antibody: diagnostic value and correlation to PCR.

Authors:  K Siemoneit; M da Silva Cardoso; A Wölpl; S Epple; H Wintersinger; K Koerner; B Kubanek
Journal:  Ann Hematol       Date:  1994-09       Impact factor: 3.673

7.  Hepatitis C virus (HCV) core serotypes in chronic HCV infection.

Authors:  M U Mondelli; A Cerino; F Bono; A Cividini; A Maccabruni; M Aricò; A Malfitano; G Barbarini; V Piazza; L Minoli
Journal:  J Clin Microbiol       Date:  1994-10       Impact factor: 5.948

8.  The evaluation of hepatitis C virus core antigen in immunized BALB/c mice.

Authors:  Elham Torbati; Mojgan Bandehpour; Parviz Pakzad; Nariman Mosaffa; Ameneh Koochaki; Bahram Kazemi
Journal:  Hepat Mon       Date:  2012-06-30       Impact factor: 0.660

9.  Bioinformatics Analysis of Domain 1 of HCV-Core Protein: Iran.

Authors:  Behzad Dehghani; Tayebeh Hashempour; Zahra Hasanshahi; Javad Moayedi
Journal:  Int J Pept Res Ther       Date:  2019-04-20       Impact factor: 1.931

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.